Stock listing

Stuttgart:NNFN MannKind Corporation Aktie

German listing (Stuttgart) of MannKind Corporation · home listing NASDAQ:MNKD

Follow MannKind Corporation into a list and get an email when it puts out news.

Home listing price · NASDAQ:MNKD

$3.85 USD -0.22 (-5.4%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:MNKD

Past year -22.5% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$3.83 – $4.08 USDNov 20, 2026
Volume
4.18M sharesNov 20, 2026
Market cap
$1.24B USDAt the close on Nov 20, 2026 · price × 321.6M shares outstanding
52-week range
$2.23 – $6.51 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$14.45M USDMedian day 3.17M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
MannKind Corporation logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:MNKD · Home$3.85 USD-0.22 (-5.4%)4,178,911$3.90$4.08$3.83$4.07Close on Nov 20, 2026
Frankfurt:NNFN€3.491 EUR-0.166 (-4.5%)—€3.491€3.491€3.491€3.657Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:MNKD · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$3.85-0.22-5.4%$3.90$4.08$3.834,178,911
$4.070.000.0%$4.05$4.17$4.032,293,119
$4.07+0.115+2.9%$3.96$4.18$3.903,446,797
$3.955-0.175-4.2%$4.08$4.128$3.8912,794,563
$4.13-0.03-0.7%$4.15$4.18$4.081,686,725
$4.16-0.03-0.7%$4.15$4.24$4.1053,504,940
$4.19-0.04-0.9%$4.23$4.235$4.153,283,023
$4.23+0.04+1.0%$4.18$4.285$4.074,113,131
$4.19+0.29+7.4%$3.98$4.25$3.884,829,130
$3.90+0.14+3.7%$3.92$4.095$3.804,984,501
$3.76-0.17-4.3%$3.93$3.97$3.6655,388,862
$3.93+0.20+5.4%$3.86$4.045$3.803,814,595
$3.73+0.08+2.2%$3.66$3.76$3.6194,867,021
$3.65+0.15+4.3%$3.50$3.66$3.463,174,857
$3.500.000.0%$3.50$3.57$3.452,009,438
$3.50+0.07+2.0%$3.49$3.57$3.482,271,081
$3.43+0.14+4.3%$3.26$3.465$3.2353,076,665
$3.29+0.06+1.9%$3.23$3.30$3.172,501,299
$3.23+0.04+1.3%$3.22$3.275$3.151,976,493
$3.19-0.01-0.3%$3.18$3.21$3.093,088,400
$3.20+0.15+4.9%$3.03$3.21$3.013,254,700
$3.05-0.05-1.6%$3.10$3.13$3.042,798,700
$3.10+0.01+0.3%$3.11$3.18$3.082,170,400
$3.09+0.05+1.6%$3.18$3.22$3.072,463,000
$3.04-0.15-4.7%$3.20$3.24$3.022,605,500
$3.19+0.17+5.6%$3.02$3.20$3.003,756,500
$3.02-0.03-1.0%$3.00$3.13$2.907,933,900
$3.05-0.08-2.6%$3.13$3.14$3.024,394,000
$3.13-0.16-4.9%$3.24$3.27$3.083,957,000
$3.29-0.13-3.8%$3.40$3.41$3.234,549,500
$3.42-0.03-0.9%$3.42$3.53$3.334,539,700
$3.45-0.26-7.0%$3.67$3.68$3.396,005,300
$3.71-0.11-2.9%$3.86$3.86$3.693,069,900
$3.82+0.02+0.5%$3.82$3.85$3.702,876,200
$3.80-0.15-3.8%$4.01$4.01$3.714,610,100
$3.95+0.05+1.3%$3.84$4.23$3.8310,190,800
$3.90+0.56+16.8%$3.37$4.03$3.3015,020,200
$3.34-0.01-0.3%$3.35$3.38$3.282,378,100
$3.35+0.01+0.3%$3.34$3.38$3.282,077,500
$3.34+0.05+1.5%$3.32$3.39$3.178,852,600
$3.29-0.05-1.5%$3.33$3.33$3.232,964,300
$3.34-0.15-4.3%$3.48$3.48$3.342,874,900
$3.49-0.01-0.3%$3.53$3.55$3.2616,298,900
$3.50-0.04-1.1%$3.55$3.62$3.474,524,600
$3.54-0.04-1.1%$3.59$3.62$3.505,512,800
$3.58+0.03+0.8%$3.61$3.68$3.532,733,100
$3.55-0.01-0.3%$3.57$3.61$3.522,225,500
$3.56-0.19-5.1%$3.74$3.75$3.543,697,300
$3.750.000.0%$3.76$3.84$3.733,129,200
$3.75-0.04-1.1%$3.83$3.85$3.732,469,800
$3.79-0.15-3.8%$3.90$3.90$3.763,209,500
$3.94-0.22-5.3%$4.16$4.36$3.925,190,100
$4.16+0.10+2.5%$4.00$4.32$4.004,930,900
$4.06+0.10+2.5%$3.92$4.10$3.922,806,300
$3.96-0.08-2.0%$4.05$4.07$3.962,331,100
$4.04+0.06+1.5%$3.97$4.09$3.972,590,500
$3.98-0.03-0.7%$3.97$4.03$3.952,234,800
$4.01+0.06+1.5%$3.94$4.02$3.902,805,200
$3.95-0.11-2.7%$4.06$4.08$3.931,984,100
$4.06-0.03-0.7%$4.05$4.12$4.042,067,800
$4.09-0.07-1.7%$4.16$4.19$4.051,766,300
$4.16+0.09+2.2%$4.10$4.235$4.103,193,655
$4.07-0.08-1.9%$4.13$4.14$4.062,812,485
$4.15-0.11-2.6%$4.28$4.36$4.113,204,500
$4.26-0.14-3.2%$4.35$4.36$4.143,416,000

Splits

1 split · NASDAQ:MNKD · every price before a split is adjusted for it

DayRatioWhat
1-for-5Consolidation
Ticker
Stuttgart:NNFN
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Stuttgart
Currency
EUR

What changed lately

Latest news

All MannKind Corporation news

MannKind Corporation on 6ix

Sector
Health care
Industry
Biotechnology
News releases
33 in the last 12 months · 208 in all · newest Nov 10, 2026 · oldest 2019
Calls
21 calls with a replay · 21 with a transcript · latest Nov 5, 2026
Decks
9 decks · latest Aug 5, 2026

Where MannKind Corporation is listed

ListingExchangeCountryCurrency
NASDAQ:MNKD · Home listingNASDAQUnited StatesUSD
BOATS:MNKDBOATSUnited StatesUSD
gettex:NNFNgettexGermanyEUR
LS Exchange:A2DMZLLS ExchangeGermanyEUR
Lang & Schwarz:A2DMZLLang & SchwarzGermanyEUR
Tradegate:NNFNTradegateGermanyEUR
Munich:NNFNMunichGermanyEUR
BX Swiss:NNFNBX SwissSwitzerlandCHF
Dusseldorf:NNFNDusseldorfGermanyEUR
Frankfurt:NNFNFrankfurtGermanyEUR
Stuttgart:NNFN · This pageStuttgartGermanyEUR

Valuation

EV/sales 3.5× against a median of 90.4×: 2nd lowest of 7 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$1.46B USD
P/E
Loss
EV/sales
3.5×
EV/EBITDA
309×
Price/book
Negative equity
Gross margin
76.0%
Operating margin
−2.9%
Net margin
−18.1%
Debt to equity
Negative equity
Beta vs S&P 500
1.06

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
MannKind Corporation · NASDAQ:MNKDUS$1.24BUS$1.46Bn/a3.5×309×n/a−18.1%n/a1.06
Absci Corporation · NASDAQ:ABSIUS$1.30BUS$1.13Bn/a758×n/a5.9×n/a0.0×3.20
Avalyn Pharma Inc. · NASDAQ:AVLNUS$1.26BUS$946.4Mn/an/an/a3.4×n/a0.0×0.12
LB Pharmaceuticals Inc · NASDAQ:LBRXUS$1.26BUS$858.7Mn/an/an/a3.0×n/a0.0×0.81
Novavax, Inc. · NASDAQ:NVAXUS$1.23BUS$902.3Mn/a2.2×n/an/a−18.6%n/a1.98
Silence Therapeutics PLC · NASDAQ:SLNUS$1.23BUS$984.6Mn/a2,159×n/a5.7×n/a0.0×1.07
Ocular Therapeutix, Inc. · NASDAQ:OCULUS$1.23BUS$774.9Mn/a15.4×n/a2.8×−648.6%0.2×1.35
Generate Biomedicines, Inc. · NASDAQ:GENBUS$1.22BUS$895.6Mn/a28.1×n/a3.2×−637.0%0.2×1.90
Taysha Gene Therapies, Inc. · NASDAQ:TSHAUS$1.21BUS$837.4Mn/a153×n/a3.4×n/a0.1×1.69
Mineralys Therapeutics, Inc. · NASDAQ:MLYSUS$1.21BUS$585.1Mn/an/an/a2.4×n/a0.0×1.39
GH Research PLC · NASDAQ:GHRSUS$1.20BUS$841.0Mn/an/an/a3.4×n/a0.0×1.28
Median of the othersUS$1.23BUS$877.2M90.4×3.4×−637.0%0.0×1.37

Forecasts

8 strong buy · 1 hold · Analysts' consensus from EODHD, read Nov 15, 2026. Not 6ix's view and not investment advice.

Price target
8.33 USD · Analysts' mean
EPS, year to Dec 2026
0.015 · 4 analysts
Revenue, year to Dec 2026
434.6M · 7 analysts

Team and board

Officers

OfficerRole
Michael CastagnaChief Executive Officer
Chris PrentissChief Financial Officer
David ThomsonGeneral Counsel and Corporate Secretary
Kate MirandaInvestor Relations
Sanjay SinghExecutive Vice President, Technical Operations MannKind
Ajay AhujaChief Medical Officer
Alfred E. MannFounder
Stuart TrossChief People and Workplace Officer

Board

DirectorRole
James ShannonChairman of the Board
Anthony HooperAudit Committee member, Compensation Committee Chair
Christine MundkurAudit Committee member, Nominating and Corporate Governance Committee member
Jennifer GrancioAudit Committee member, Nominating and Corporate Governance Committee chair
Michael CastagnaChief Executive Officer
Michael FriedmanNominating and Corporate Governance Committee member
Ronald ConsiglioAudit Committee chair
Sabrina KayAudit Committee member, Compensation Committee member

Events

Calls

CallWhenStatus
MannKind (NASDAQ:MNKD) Q3 2026 Earnings CallThu, Nov 05, 2026 · 4:30 PM ETReplay
MannKind (NASDAQ:MNKD) Q2 2026 Earnings CallWed, Aug 05, 2026 · 4:30 PM ETReplay
MannKind (NASDAQ:MNKD) Q1 2026 Earnings CallWed, May 06, 2026 · 4:30 PM ETReplay
MannKind (NASDAQ:MNKD) Q4 2025 Earnings CallThu, Feb 26, 2026 · 9:00 AM ETReplay
MannKind (NASDAQ:MNKD) Q3 2025 Earnings CallWed, Nov 05, 2025 · 9:00 AM ETReplay
MannKind (NASDAQ:MNKD) Q2 2025 Earnings CallWed, Aug 06, 2025 · 9:00 AM ETReplay
MannKind (NASDAQ:MNKD) Q1 2025 Earnings CallThu, May 08, 2025 · 9:00 AM ETReplay
MannKind (NASDAQ:MNKD) Q4 2024 Earnings CallWed, Feb 26, 2025 · 4:30 PM ETReplay
MannKind (NASDAQ:MNKD) Q3 2024 Earnings CallThu, Nov 07, 2024 · 4:30 PM ETReplay
MannKind (NASDAQ:MNKD) Q2 2024 Earnings CallWed, Aug 07, 2024 · 9:00 AM ETReplay
All 21 calls
CallWhenStatus
MannKind (NASDAQ:MNKD) Q1 2024 Earnings CallWed, May 08, 2024 · 5:00 PM ETReplay
MannKind (NASDAQ:MNKD) Q4 2023 Earnings CallTue, Feb 27, 2024 · 5:00 PM ETReplay
MannKind (NASDAQ:MNKD) Q3 2023 Earnings CallTue, Nov 07, 2023 · 5:00 PM ETReplay
MannKind (NASDAQ:MNKD) Q2 2023 Earnings CallMon, Aug 07, 2023 · 5:00 PM ETReplay
MannKind (NASDAQ:MNKD) Q1 2023 Earnings CallTue, May 09, 2023 · 5:00 PM ETReplay
MannKind (NASDAQ:MNKD) Q4 2022 Earnings CallThu, Feb 23, 2023 · 5:00 PM ETReplay
MannKind (NASDAQ:MNKD) Q3 2022 Earnings CallTue, Nov 08, 2022 · 9:00 AM ETReplay
MannKind (NASDAQ:MNKD) Q2 2022 Earnings CallTue, Aug 09, 2022 · 5:00 PM ETReplay
MannKind (NASDAQ:MNKD) Q1 2022 Earnings CallThu, May 05, 2022 · 5:00 PM ETReplay
MannKind (NASDAQ:MNKD) Q3 2021 Earnings CallTue, Nov 09, 2021 · 5:00 PM ETReplay
MannKind (NASDAQ:MNKD) Q2 2021 Earnings CallWed, Aug 11, 2021 · 5:00 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 5, 2026 · After close+3.7%
Q2 2026Aug 5, 2026 · After close−5.1%
Q1 2026May 7, 2026−1.1%
Q4 2025Feb 26, 2026 · Before open−7.4%
Q3 2025Nov 5, 2025 · Before open+10.6%
Q2 2025Aug 6, 2025 · Before open−13.0%
Q1 2025May 6, 2025 · Before open−3.6%
Q4 2024Feb 26, 2025 · After close−4.4%
Q3 2024Nov 7, 2024 · After close−0.5%
Q2 2024Aug 7, 2024 · Before open−4.9%
All 20 quarters
QuarterResultsShare move
Q1 2024May 8, 2024 · After close−2.0%
Q4 2023Feb 27, 2024 · After close+3.7%
Q3 2023Nov 7, 2023 · After close−4.0%
Q2 2023Aug 7, 2023 · After close+18.5%
Q1 2023May 9, 2023 · After close+15.8%
Q4 2022Feb 22, 2023 · Before open−1.5%
Q3 2022Nov 8, 2022 · Before open+5.0%
Q2 2022Aug 9, 2022 · After close+4.9%
Q1 2022May 5, 2022 · After close−3.9%
Q4 2021Feb 24, 2022 · After close−6.5%

Open Events

Decks

DeckKindSlidesDate
Q2 2026 Earnings PresentationEarnings36 slidesAug 5, 2026
Investor Presentation (August 2026)Investor deck34 slidesAugust 2026
Technical Presentation (July 2026)Technical34 slidesJul 29, 2026
Corporate Update (July 2026)Corporate update23 slidesJul 24, 2026
Q4 2025 Earnings PresentationEarnings31 slidesFeb 26, 2026
Q3 2025 Earnings PresentationEarnings34 slidesNov 5, 2025
Merger or Acquisition (August 2025)Merger or acquisition15 slidesAug 25, 2025
J.P. Morgan Healthcare Conference 2016Conference14 slidesJan 13, 2016
Fact Sheet (June 2011)Fact sheet2 slidesJune 2011

Open Decks

Financings

RaiseDate
Private placement of unstated
Closed: US$50M raised · US$3.89 a share
Buyers: Frazier Life Sciences
Use of proceeds: To fund the $45 million CVR payment triggered by the FDA approval of Furoscix ReadyFlow
Aug 5, 2026

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue349.0M285.5M199.0M99.8M75.4M65.1M63.0M27.9M11.7M174.8M
Cost of revenue26.8M17.4M20.9M16.0M16.8M15.1M20.1M19.4M17.2M17.1M
Gross profit287.8M208.9M136.2M42.3M36.6M40.5M35.1M7.38M-5.48M124.7M
Research and development66.3M45.9M31.3M19.7M12.3M6.25M6.90M8.74M14.1M14.9M
Selling, general and administrative144.1M94.3M94.3M91.5M77.4M59.0M74.7M79.7M75.0M46.9M
Operating income38.8M72.6M8.68M-64.1M-47.0M-47.9M-44.6M-76.6M-108.2M67.3M
Depreciation and amortization12.3M7.37M4.54M3.33M1.99M2.15M972.0K2.86M1.80M2.40M
EBITDA51.1M80.0M13.2M-60.8M-45.0M-45.8M-43.6M-73.7M-106.4M69.7M
Interest expense13.8M12.0M15.2M15.0M15.2M9.47M6.30M5.12M9.49M15.6M
Income before tax1.41M30.5M-10.4M-87.4M-80.9M-57.5M-51.9M-86.7M-117.3M125.7M
Income tax-4.46M2.93M1.56M00-218.0K0240.0K51.0K0
Net income5.86M27.6M-11.9M-87.4M-80.9M-57.2M-51.9M-87.0M-117.3M125.7M
Earnings per share, basic0.020.10-0.04-0.34-0.32-0.26-0.27-0.60-1.131.37
Earnings per share, diluted0.020.10-0.04-0.34-0.32-0.26-0.27-0.60-1.131.36

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents74.9M46.3M238.5M69.8M124.2M67.0M29.9M71.2M43.9M22.9M
Short-term investments96.5M150.9M56.6M101.1M79.9M020.0M4.81M350.0K
Receivables38.4M11.8M14.9M16.8M4.74M4.22M3.51M4.02M2.79M302.0K
Inventory35.3M27.9M28.5M21.8M7.15M4.97M4.16M3.60M2.66M2.33M
Current assets291.6M268.3M373.4M234.9M219.5M79.5M60.8M81.9M57.2M77.5M
Property, plant and equipment82.4M85.4M84.2M45.1M36.6M25.9M26.8M25.6M26.9M28.9M
Goodwill67.6M1.93M1.93M2.43M000
Total assets792.2M393.8M475.2M295.3M321.2M108.6M93.7M107.7M84.6M107.1M
Accounts payable9.03M6.79M9.58M11.1M6.96M5.58M4.79M5.38M6.98M3.26M
Current liabilities171.0M81.8M104.1M67.3M48.3M73.7M65.6M75.2M87.6M92.1M
Long-term debt318.4M36.1M248.7M368.0M223.9M5.00M113.9M91.2M104.1M77.2M
Total debt354.6M36.1M268.7M273.5M281.2M122.2M118.9M102.5M156.8M148.5M
Total liabilities843.2M472.7M721.4M545.8M530.5M289.0M284.3M282.8M299.3M290.7M
Shareholders' equity-51.0M-78.8M-246.2M-250.5M-209.3M-180.4M-190.5M-175.1M-214.7M-183.6M
Shares outstanding307.8M303.0M270.0M263.8M251.5M242.1M211.8M187.0M119.1M95.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations18.3M42.5M34.1M-80.7M-61.7M-28.1M-88.5M-37.7M-64.8M-78.1M
Capital spending-4.57M-9.69M-42.4M-7.59M-11.5M-801.0K-2.56M-354.0K-1.14M-1.14M
Free cash flow13.7M32.8M-8.35M-88.3M-73.2M-28.9M-91.0M-38.1M-64.8M-79.2M
Cash from investing-304.8M-96.6M-1.99M4.87M-151.5M15.2M-22.8M-234.0K16.7M-1.13M
Cash from financing315.1M-137.3M136.6M21.4M270.3M49.9M69.9M61.3M73.6M43.0M
Dividends paid-498.0K-14.9M-656.0K00
Share buybacks-3.26M-10.2M19.4M-498.0K684.0K656.0K67.9M-127.0K-165.0K
Change in cash28.6M-191.4M168.7M-54.4M57.0M36.9M-41.5M23.3M25.5M-36.2M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 19, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeNov 10, 2026Big-stake noticeSEC
10-Q · Quarterly reportNov 5, 2026Quarterly reportSEC
8-K · Current reportNov 5, 2026ResultsSEC
4 · Change in ownershipSep 28, 2026Insider tradeSEC
144 · Notice of proposed saleSep 25, 2026Other filingsSEC
4 · Change in ownershipSep 14, 2026Insider tradeSEC
144 · Notice of proposed saleSep 10, 2026Other filingsSEC
8-K · Current reportAug 21, 2026Current reportSEC
424B7 · ProspectusAug 21, 2026Offer documentSEC
Show 200 filings
FilingDateTypeFiled with
SCHEDULE 13G · Big-stake noticeAug 14, 2026Big-stake noticeSEC
4 · Change in ownershipAug 10, 2026Insider tradeSEC
144 · Notice of proposed saleAug 7, 2026Other filingsSEC
10-Q · Quarterly reportAug 5, 2026Quarterly reportSEC
8-K · Current reportAug 5, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeJul 31, 2026Big-stake noticeSEC
8-K · Current reportJul 24, 2026FinancingSEC
4 · Change in ownershipJul 17, 2026Insider tradeSEC
4 · Change in ownershipJul 17, 2026Insider tradeSEC
4 · Change in ownershipJul 17, 2026Insider tradeSEC
4 · Change in ownershipJul 17, 2026Insider tradeSEC
4 · Change in ownershipJul 17, 2026Insider tradeSEC
4 · Change in ownershipJul 17, 2026Insider tradeSEC
4 · Change in ownershipJul 17, 2026Insider tradeSEC
144 · Notice of proposed saleJul 17, 2026Other filingsSEC
144 · Notice of proposed saleJul 17, 2026Other filingsSEC
8-K · Current reportJun 2, 2026Current reportSEC
8-K · Current reportMay 28, 2026Current reportSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
8-K · Current reportMay 22, 2026Meeting outcomeSEC
144/A · Notice of proposed sale, amendedMay 14, 2026Other filingsSEC
4 · Change in ownershipMay 13, 2026Insider tradeSEC
4 · Change in ownershipMay 13, 2026Insider tradeSEC
4 · Change in ownershipMay 13, 2026Insider tradeSEC
4 · Change in ownershipMay 13, 2026Insider tradeSEC
144 · Notice of proposed saleMay 12, 2026Other filingsSEC
144 · Notice of proposed saleMay 12, 2026Other filingsSEC
SCHEDULE 13G · Big-stake noticeMay 12, 2026Big-stake noticeSEC
4/A · Change in ownership, amendedMay 8, 2026Insider tradeSEC
10-Q · Quarterly reportMay 6, 2026Quarterly reportSEC
8-K · Current reportMay 6, 2026ResultsSEC
4 · Change in ownershipApr 24, 2026Insider tradeSEC
ARS · Annual report to shareholdersApr 7, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 7, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 7, 2026Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 27, 2026Big-stake noticeSEC
4 · Change in ownershipMar 25, 2026Insider tradeSEC
4 · Change in ownershipMar 25, 2026Insider tradeSEC
4 · Change in ownershipMar 25, 2026Insider tradeSEC
4 · Change in ownershipMar 25, 2026Insider tradeSEC
4 · Change in ownershipMar 25, 2026Insider tradeSEC
4 · Change in ownershipMar 25, 2026Insider tradeSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
10-K · Annual reportFeb 26, 2026Annual reportSEC
8-K · Current reportFeb 26, 2026ResultsSEC
4 · Change in ownershipJan 9, 2026Insider tradeSEC
144 · Notice of proposed saleJan 8, 2026Other filingsSEC
4 · Change in ownershipDec 29, 2025Insider tradeSEC
4 · Change in ownershipDec 19, 2025Insider tradeSEC
4 · Change in ownershipDec 16, 2025Insider tradeSEC
8-K/A · Current report, amendedDec 15, 2025Current reportSEC
144 · Notice of proposed saleDec 12, 2025Other filingsSEC
4 · Change in ownershipDec 4, 2025Insider tradeSEC
4 · Change in ownershipDec 4, 2025Insider tradeSEC
144 · Notice of proposed saleDec 2, 2025Other filingsSEC
144 · Notice of proposed saleDec 2, 2025Other filingsSEC
4 · Change in ownershipNov 14, 2025Insider tradeSEC
144 · Notice of proposed saleNov 14, 2025Other filingsSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
8-K · Current reportNov 10, 2025Current reportSEC
10-Q · Quarterly reportNov 5, 2025Quarterly reportSEC
8-K · Current reportNov 5, 2025ResultsSEC
4 · Change in ownershipNov 3, 2025Insider tradeSEC
3 · Initial statement of ownershipOct 9, 2025Insider tradeSEC
8-K · Current reportOct 9, 2025Acquisition or disposalSEC
SC TO-T/AOct 7, 2025Acquisition or disposalSEC
SC TO-T/ASep 30, 2025Acquisition or disposalSEC
SC TO-T/ASep 29, 2025Acquisition or disposalSEC
SC TO-T/ASep 24, 2025Acquisition or disposalSEC
SC TO-T/ASep 22, 2025Acquisition or disposalSEC
4 · Change in ownershipSep 17, 2025Insider tradeSEC
144 · Notice of proposed saleSep 16, 2025Other filingsSEC
SC TO-TSep 8, 2025Acquisition or disposalSEC
8-K · Current reportAug 27, 2025Material contractSEC
SC TO-CAug 25, 2025Other filingsSEC
SC TO-CAug 25, 2025Other filingsSEC
SC TO-CAug 25, 2025Other filingsSEC
8-K · Current reportAug 25, 2025Material contractSEC
4 · Change in ownershipAug 6, 2025Insider tradeSEC
10-Q · Quarterly reportAug 6, 2025Quarterly reportSEC
8-K · Current reportAug 6, 2025ResultsSEC
UPLOAD · Letter from the SECJul 24, 2025Other filingsSEC
CORRESP · Letter to the SECJul 18, 2025Other filingsSEC
4 · Change in ownershipJul 17, 2025Insider tradeSEC
4 · Change in ownershipJul 17, 2025Insider tradeSEC
4 · Change in ownershipJul 17, 2025Insider tradeSEC
4 · Change in ownershipJul 17, 2025Insider tradeSEC
4 · Change in ownershipJul 17, 2025Insider tradeSEC
4 · Change in ownershipJul 17, 2025Insider tradeSEC
4 · Change in ownershipJul 17, 2025Insider tradeSEC
4 · Change in ownershipJul 17, 2025Insider tradeSEC
144 · Notice of proposed saleJul 16, 2025Other filingsSEC
144 · Notice of proposed saleJul 16, 2025Other filingsSEC
UPLOAD · Letter from the SECJul 14, 2025Other filingsSEC
CORRESP · Letter to the SECJul 2, 2025Other filingsSEC
4 · Change in ownershipJun 25, 2025Insider tradeSEC
UPLOAD · Letter from the SECJun 18, 2025Other filingsSEC
4 · Change in ownershipJun 10, 2025Insider tradeSEC
144 · Notice of proposed saleJun 10, 2025Other filingsSEC
CORRESP · Letter to the SECJun 5, 2025Other filingsSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4/A · Change in ownership, amendedMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 20, 2025Insider tradeSEC
4 · Change in ownershipMay 20, 2025Insider tradeSEC
4 · Change in ownershipMay 20, 2025Insider tradeSEC
4 · Change in ownershipMay 20, 2025Insider tradeSEC
144 · Notice of proposed saleMay 20, 2025Other filingsSEC
144 · Notice of proposed saleMay 20, 2025Other filingsSEC
8-K · Current reportMay 19, 2025Meeting outcomeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
UPLOAD · Letter from the SECMay 16, 2025Other filingsSEC
4 · Change in ownershipMay 15, 2025Insider tradeSEC
4 · Change in ownershipMay 15, 2025Insider tradeSEC
4 · Change in ownershipMay 15, 2025Insider tradeSEC
4 · Change in ownershipMay 15, 2025Insider tradeSEC
4 · Change in ownershipMay 15, 2025Insider tradeSEC
4 · Change in ownershipMay 15, 2025Insider tradeSEC
8-K · Current reportMay 15, 2025Management or board changeSEC
144 · Notice of proposed saleMay 13, 2025Other filingsSEC
144 · Notice of proposed saleMay 13, 2025Other filingsSEC
10-Q · Quarterly reportMay 8, 2025Quarterly reportSEC
8-K · Current reportMay 8, 2025ResultsSEC
4 · Change in ownershipApr 4, 2025Insider tradeSEC
ARS · Annual report to shareholdersApr 1, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 1, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 1, 2025Meeting noticeSEC
4 · Change in ownershipMar 28, 2025Insider tradeSEC
4/A · Change in ownership, amendedMar 28, 2025Insider tradeSEC
S-3ASR · Registration statementFeb 26, 2025Offer documentSEC
10-K · Annual reportFeb 26, 2025Annual reportSEC
8-K · Current reportFeb 26, 2025ResultsSEC
4 · Change in ownershipFeb 13, 2025Insider tradeSEC
3 · Initial statement of ownershipJan 29, 2025Insider tradeSEC
8-K · Current reportJan 6, 2025Management or board changeSEC
8-K · Current reportDec 18, 2024FinancingSEC
4 · Change in ownershipNov 25, 2024Insider tradeSEC
144 · Notice of proposed saleNov 22, 2024Other filingsSEC
4 · Change in ownershipNov 19, 2024Insider tradeSEC
144 · Notice of proposed saleNov 15, 2024Other filingsSEC
4 · Change in ownershipNov 8, 2024Insider tradeSEC
10-Q · Quarterly reportNov 7, 2024Quarterly reportSEC
8-K · Current reportNov 7, 2024ResultsSEC
144 · Notice of proposed saleNov 6, 2024Other filingsSEC
4 · Change in ownershipNov 4, 2024Insider tradeSEC
4 · Change in ownershipSep 4, 2024Insider tradeSEC
144 · Notice of proposed saleSep 3, 2024Other filingsSEC
4 · Change in ownershipAug 30, 2024Insider tradeSEC
144 · Notice of proposed saleAug 30, 2024Other filingsSEC
4 · Change in ownershipAug 29, 2024Insider tradeSEC
4 · Change in ownershipAug 29, 2024Insider tradeSEC
4 · Change in ownershipAug 29, 2024Insider tradeSEC
4 · Change in ownershipAug 29, 2024Insider tradeSEC
144 · Notice of proposed saleAug 29, 2024Other filingsSEC
144 · Notice of proposed saleAug 29, 2024Other filingsSEC
144 · Notice of proposed saleAug 29, 2024Other filingsSEC
8-K · Current reportAug 14, 2024Management or board changeSEC
8-K · Current reportAug 7, 2024ResultsSEC
10-Q · Quarterly reportAug 7, 2024Quarterly reportSEC
4 · Change in ownershipJul 17, 2024Insider tradeSEC
4 · Change in ownershipJul 17, 2024Insider tradeSEC
4 · Change in ownershipJul 17, 2024Insider tradeSEC
4 · Change in ownershipJul 17, 2024Insider tradeSEC
4 · Change in ownershipJul 17, 2024Insider tradeSEC
4 · Change in ownershipJul 17, 2024Insider tradeSEC
144 · Notice of proposed saleJul 16, 2024Other filingsSEC
144 · Notice of proposed saleJul 16, 2024Other filingsSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from MannKind Corporation’s releases · as of Oct 23, 2026

Common shares
321,640,118
Fully diluted
321,640,118

Fully diluted

LineSharesAs of
Common shares321,640,118Oct 23, 2026

Share count over time

CountShares
Oct 23, 2026321,640,118

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
BlackRock32.9M10.2%US$128MSep 30, 2026
Rubric Capital Management LP29.4M9.1%US$115MSep 30, 2026
Vanguard20M6.2%US$78.1MSep 30, 2026
Frazier Life Sciences Management, L.P.15.8M4.9%US$61.4MSep 30, 2026
State Street15.1M4.7%US$58.9MSep 30, 2026
Geode Capital8.05M2.5%US$31.4MSep 30, 2026
Deep Track Capital, LP5.03M1.6%US$19.6MSep 30, 2026
180 Wealth Advisors, LLC4.99M1.6%US$19.4MSep 30, 2026
Fidelity4.54M1.4%US$17.7MSep 30, 2026
TSP Capital Management Group, LLC4.18M1.3%US$16.3MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Goldman Sachs3.14M0.98%US$12.3MSep 30, 2026
Northern Trust2.91M0.90%US$11.4MSep 30, 2026
Schwab2.87M0.89%US$11.2MSep 30, 2026
Morgan Stanley2.77M0.86%US$10.8MSep 30, 2026
UBS2.77M0.86%US$10.8MSep 30, 2026
Two Sigma2.48M0.77%US$9.68MSep 30, 2026
First Trust1.87M0.58%US$7.3MSep 30, 2026
Woodline Partners LP1.83M0.57%US$7.14MSep 30, 2026
Bank of America1.66M0.52%US$6.49MSep 30, 2026
AQR Capital Management LLC1.44M0.45%US$5.62MSep 30, 2026
Janus Henderson1.4M0.44%US$5.46MSep 30, 2026
Ameriprise1.37M0.43%US$5.35MSep 30, 2026
Point72 Asset Management, L.P.1.22M0.38%US$4.76MSep 30, 2026
J. Goldman & Co LP1.17M0.36%US$4.58MSep 30, 2026
Wells Fargo935K0.29%US$3.65MSep 30, 2026
BNY925K0.29%US$3.61MSep 30, 2026
Millennium920K0.29%US$3.59MSep 30, 2026
Boothbay Fund Management, LLC897K0.28%US$3.5MSep 30, 2026
Voya Investment Management LLC738K0.23%US$2.88MSep 30, 2026
Deltec Asset Management LLC728K0.23%US$2.84MSep 30, 2026
Susquehanna717K0.22%US$2.8MSep 30, 2026
Nuveen651K0.20%US$2.54MSep 30, 2026
Diadema Partners LP604K0.19%US$2.36MSep 30, 2026
Swiss National Bank587K0.18%US$2.29MSep 30, 2026
1492 Capital Management LLC517K0.16%US$2.02MSep 30, 2026
State Of Wisconsin Investment Board513K0.16%US$2MSep 30, 2026
Jump Financial, LLC496K0.15%US$1.94MSep 30, 2026
Squarepoint Ops LLC496K0.15%US$1.93MSep 30, 2026
T. Rowe Price473K0.15%US$1.85MSep 30, 2026
Schonfeld Strategic Advisors LLC441K0.14%US$1.72MSep 30, 2026
Alps Advisors Inc426K0.13%US$1.66MSep 30, 2026
Citadel397K0.12%US$1.55MSep 30, 2026
ExodusPoint Capital Management, LP395K0.12%US$1.54MSep 30, 2026
Rhumbline Advisers365K0.11%US$1.42MSep 30, 2026
California State Teachers Retirement System343K0.11%US$1.34MSep 30, 2026
Barclays341K0.11%US$1.33MSep 30, 2026
Sei Investments Co339K0.11%US$1.32MSep 30, 2026
Rafferty Asset Management, LLC311K0.10%US$1.21MSep 30, 2026
DWS308K0.10%US$1.2MSep 30, 2026
Mariner, LLC304K0.09%US$1.18MSep 30, 2026

This page holds 50 of 242 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund9.33M2.9%US$39.7MJun 30, 2026
State Street(R) SPDR(R) S&P(R) Biotech ETF8.52M2.6%US$36.3MJun 30, 2026
iShares Russell 2000 ETF7.99M2.5%US$34MJun 30, 2026
Select Biotechnology Portfolio4.08M1.3%US$15.4MMay 31, 2026
Vanguard Extended Market Index Fund3.53M1.1%US$15MJun 30, 2026
Fidelity Small Cap Index Fund3.36M1.0%US$13.1MJul 31, 2026
iShares Russell 2000 Growth ETF2.84M0.88%US$12.1MJun 30, 2026
iShares Biotechnology ETF2.08M0.65%US$8.85MJun 30, 2026
Janus Henderson Small/Mid Cap Growth Alpha ETF1.68M0.52%US$6.56MJul 31, 2026
Fidelity Extended Market Index Fund1.59M0.49%US$6MMay 31, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Vanguard Russell 2000 Index Fund1.57M0.49%US$5.92MMay 31, 2026
Schwab U.S. Small-Cap ETF1.47M0.46%US$5.53MMay 31, 2026
BlackRock Advantage Small Cap Core Fund1.33M0.42%US$5.03MMay 29, 2026
First Trust Small Cap Growth AlphaDEX Fund1.21M0.38%US$4.74MJul 31, 2026
Vanguard Health Care Index Fund870K0.27%US$3.28MMay 31, 2026
Schwab Small-Cap Index Fund748K0.23%US$2.93MJul 31, 2026
VictoryShares Small Cap Free Cash Flow ETF617K0.19%US$2.63MJun 30, 2026
Small Cap Growth Stock Portfolio592K0.18%US$2.52MJun 30, 2026
Fidelity Total Market Index Fund575K0.18%US$2.17MMay 31, 2026
Master Small Cap Index Series547K0.17%US$2.33MJun 30, 2026
Fidelity Series Total Market Index Fund468K0.15%US$1.76MMay 31, 2026
iShares Core S&P Total U.S. Stock Market ETF462K0.14%US$1.97MJun 30, 2026
Janus Henderson Small Cap Growth Alpha ETF451K0.14%US$1.76MJul 31, 2026
Hartford Small Cap Growth Hls Fund438K0.14%US$1.87MJun 30, 2026
First Trust Small Cap Core AlphaDEX Fund410K0.13%US$1.6MJul 31, 2026
Nuveen Small Cap Blend Index Fund408K0.13%US$1.6MJul 31, 2026
State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF369K0.11%US$1.57MJun 30, 2026
Principal U.S. Small-Cap ETF355K0.11%US$1.51MJun 30, 2026
EQ/2000 Managed Volatility Portfolio333K0.10%US$1.42MJun 30, 2026
BlackRock Advantage Small Cap Growth Fund332K0.10%US$1.42MJun 30, 2026
ALPS Medical Breakthroughs ETF318K0.10%US$1.2MMay 31, 2026
Direxion Daily S&P Biotech Bull 3X Shares289K0.09%US$1.13MJul 31, 2026
Fidelity Small Cap Growth Index Fund288K0.09%US$1.23MJun 30, 2026
Strategic Advisers U.S. Total Stock Fund287K0.09%US$1.08MMay 31, 2026
Vanguard Russell 2000 Growth Index Fund286K0.09%US$1.08MMay 31, 2026
LVIP State Street Small-Cap Index Fund219K0.07%US$932KJun 30, 2026
iShares ESG Aware MSCI USA Small-Cap ETF205K0.06%US$772KMay 31, 2026
The Hartford Small Cap Growth Fund202K0.06%US$788KJul 31, 2026
Schwab U.S. Broad Market ETF196K0.06%US$739KMay 31, 2026
Bruce Fund195K0.06%US$831KJun 30, 2026
Fidelity Nasdaq Composite Index Fund193K0.06%US$727KMay 31, 2026
Schwab Total Stock Market Index Fund189K0.06%US$738KJul 31, 2026
Nuveen Equity Index Fund184K0.06%US$719KJul 31, 2026
Fidelity ZERO Total Market Index Fund167K0.05%US$652KJul 31, 2026
Vanguard Balanced Index Fund159K0.05%US$676KJun 30, 2026
Small Cap Index Fund156K0.05%US$663KJun 30, 2026
U.S. Core Equity 2 Portfolio149K0.05%US$583KJul 31, 2026
EQ/Small Company Index Portfolio149K0.05%US$634KJun 30, 2026
Voya MI Dynamic SMID Cap Fund148K0.05%US$559KMay 31, 2026
Global X Russell 2000 ETF147K0.05%US$575KJul 31, 2026

This page holds 50 of 157 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Binder Steven B.
Director
Sale39,051USD 3.29US$128KSep 25, 2026
Binder Steven B.
Director
Sale33,558USD 3.81US$128KSep 10, 2026
Binder Steven B.
Director
Sale39,051USD 4.06US$159KAug 7, 2026
Binder Steven B.
Director
Sale52,485USD 4.06US$213KJul 17, 2026
Thomson David
Officer: EVP Genl Counsel & Secretary
Sale24,109USD 4.05US$97,641Jul 17, 2026
Thomson David
Officer: EVP Genl Counsel & Secretary
Sale3,033USD 3.29US$9,979May 12, 2026
Binder Steven B.
Director
Sale16,940USD 3.29US$55,733May 12, 2026

Big stakes

StakeStakeSharesDateFiling
Rubric Capital Management LP5.83%18MJun 30, 2026Schedule 13G
Vanguard Capital Management LLC5.00%15.5MJun 30, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
James Shannon
Other companies: ProQR Therapeutics N.V. (Director · Since at least Mar 18, 2026); Xilio Therapeutics, Inc. (Board Member · Since at least Jun 13, 2024); Horizon Pharma PLC (Director · Aug 2, 2017 – Aug 2, 2018 · Past); Endocyte Inc (Director · Feb 4, 2011 – May 26, 2011 · Past)
Chairman of the Board · Since at least Jun 10, 2010
Kent Kresa
Other companies: NuScale Power Corporation (Director · Since at least May 2, 2022); Avery Dennison Corporation (Director · Mar 31, 2006 – Apr 22, 2010 · Past); General Motors Company (Director · Dec 31, 2005 – Jun 7, 2010 · Past); Fluor Corporation (Director · Dec 30, 2005 – Apr 29, 2014 · Past)
Director · May 25, 2006 – May 15, 2024 · Past
Anthony Hooper
Other companies: BeOne Medicines Ltd. Class A (Director · Since at least Jun 11, 2026); Amgen Inc. (EVP, Global Commercial Ops. · Oct 27, 2011 – May 3, 2018 · Past); Bristol-Myers Squibb Company (SVP ComOps Pres USJap Int · May 3, 2010 – May 13, 2011 · Past)
Audit Committee member, Compensation Committee Chair · Since at least Jan 1, 2020
Burkhard Blank
Other companies: Acorda Therapeutics Inc (CMO and Head of R&D · Jul 1, 2016 – Mar 3, 2021 · Past)
EVP Chief Medical Officer · Since at least May 24, 2023
Christine Mundkur
Other companies: Cardinal Health, Inc. (Director · Since at least Sep 6, 2022)
Audit Committee member, Nominating and Corporate Governance Committee member · Since at least Feb 20, 2019
Richard L Anderson
Other companies: Via Pharmaceuticals Inc (Director · Dec 17, 2008 – Dec 17, 2008 · Past)
Corporate VP · Sep 26, 2008 – Sep 26, 2008 · Past
Stuart Tross
Other companies: Amgen Inc. (SVP, Human Resources · Oct 21, 2013 – May 3, 2016 · Past)
Chief People and Workplace Officer · Since at least Dec 23, 2016
Ajay AhujaChief Medical Officer · Since at least Sep 29, 2025
Alejandro GalindoEVP Endocrine Business Unit · Dec 8, 2020 – Aug 22, 2022 · Past
Alfred E. MannFounder · Since at least Nov 6, 2025
All 24 people
PersonSeat
Chris PrentissChief Financial Officer · Since at least Mar 4, 2026
David M KendallChief Medical Officer · Feb 12, 2018 – Jul 31, 2020 · Past
David ThomsonEVP Genl Counsel & Secretary · Since at least May 16, 2018
Jennifer GrancioAudit Committee member, Nominating and Corporate Governance Committee chair · Since at least Mar 23, 2020
Joseph KocinskyChief Technology Officer · May 16, 2018 – Aug 27, 2022 · Past
Kate MirandaInvestor Relations · Since at least Oct 9, 2026
Lauren M SabellaEVP Operations · Since at least Dec 31, 2023
Linda A AdrevenoSr. VP, HR · Feb 18, 2016 – Feb 18, 2016 · Past
Michael CastagnaChief Executive Officer, Director · Since at least May 11, 2026
Michael FriedmanDirector · Since at least May 10, 2022
Ronald ConsiglioAudit Committee chair · Since at least May 14, 2019
Sabrina KayAudit Committee member, Compensation Committee member · Since at least Nov 5, 2026
Sanjay SinghExecutive Vice President, Technical Operations MannKind · Since at least Oct 31, 2022
Steven B BinderDirector · Since at least Jul 25, 2017

Open People

Log in to ask 6ix AI your own questions about MannKind Corporation.